Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent
PORTLAND, Ore., Jan. 31, 2026 /PRNewswire/ — Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced
2026/02/01